That means that the mild/moderate and the severe will be known at the same moment. We need another 14 days for the remaining 17 patients (a little more than one per day). The severe study is 28 days evaluation and the mild/moderate 14 days.

In summary: everything known in the first week of July. And then we also have Samsung stock available.

But Nader unblinding earlier as he is indicating...????

The big question: do we still have patients to tread then?!

gf